PET-CT Scanner Devices Market Demand, Trends & Forecast 2024-2032

IMARC Group's report "PET-CT Scanner Devices Market Report: By Type (Stationary Scanners, Portable/Mobile Scanners), By Number of Slices (Low-Slice Scanners (< 64 Slices), Medium Slice Scanners (64 Slices), High-Slice Scanners (> 64 Slices)), by Isotope and Detector Type (Fluorodeoxyglucose (FDG), 62Cu ATSM, 18F Sodium Fluoride, FMISO, Gallium, Thallium, and Others), by Service Provider (Hospitals, Diagnostic Centers, Research Institutes), Application (Oncology, Neurology, Cardiology, and Others), and by Region 2024-2032. The global PET-CT scanner device market size reached USD 2.2 billion in 2023. Looking ahead, IMARC Group forecasts that it will reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032.

Get a Mr./Ms. pull PDF of this report: https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample

Global PET-CT Scanner Equipment Market Trends

Innovations in PET-CT imaging technology are boosting the growth of the market, such as increased image resolution, reduced scanning time, and enhanced software capabilities.

The increasing importance of personalized medicine and precision oncology is driving the adoption of PET-CT scanners for accurate diagnosis, treatment planning, and treatment response assessment.

Factors influencing the growth of the PET-CT scanner devices industry:

• Increased incidence of cancer:

PET-CT scanners are very effective in detecting cancer early, even before symptoms appear. This early detection allows for faster treatment initiation, leading to improved patient outcomes and survival. PET-CT images also provide detailed information about the spread and spread of cancer in the body, facilitating accurate staging of the disease. This information is important for creating an individualized treatment plan that is tailored to the patient's specific condition.

• Advances in Imaging Technology:

Continuous advances in PET-CT imaging technology have improved image quality, resolution, and clarity. This allows healthcare professionals to obtain more accurate and detailed images of anatomy and metabolic processes, improving the accuracy of diagnosis and increasing the reliability of clinical decision-making. In addition, innovations in PET-CT scanners have reduced scanning times, allowing healthcare facilities to increase patient throughput and efficiency. Reduced scanning time also improves patient comfort and satisfaction, reducing the overall cost and time burden associated with imaging procedures.

• Growing Demand for Personalized Medicine:

PET-CT scanners play an important role in personalized medicine by providing detailed information about the molecular and metabolic characteristics of tumors. This allows healthcare professionals to accurately diagnose cancer subtypes and assess the patient's response to specific treatments, facilitating customized treatment plans according to each patient's unique biological profile. In addition, PET-CT imaging is used to monitor patients' response to various cancer treatments, including chemotherapy, radiation therapy, and targeted therapy. By detecting metabolic changes in tumors over time, PET-CT scans can help healthcare professionals assess treatment efficacy, identify early signs of treatment resistance, and make informed decisions about adjusting or modifying treatments.

Leading companies operating in the global PET-CT Scanner Equipment industry:

• Bruker Corporation
• Canon Medical Systems USA, Inc.
• General Electric Company
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Mediso Inc.
• New Soft Inc.
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthcare GmbH (Siemens AG)
• Sophie Biosciences K.K.
• United Imaging Healthcare, Inc.
• Yangzhou Kindsway Biotechnology Co., Ltd.

PET-CT Scanner Devices Market Report Segmentation:

By Type:

• Stationary scanner
• Portable Scanners/Mobile Scanners

Stationary scanners account for the largest segment due to their high image quality, reliability, and suitability for a wide range of clinical applications.

By number of slices:

• Low-slice scanner (<64-slice)
• Medium Slice Scanner (64 Slices)
• High-Slice Scanner (> 64-slice)

Medium-slice scanners (64 slices) account for the majority of the market share due to their balance between image resolution and cost-effectiveness, making them a popular choice among healthcare professionals.

By Isotope and Detector Type:

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• gallium
• thallium
• others

Flurodeoxyglucose (FDG) shows a distinct advantage in the market due to its widespread availability, well-established efficacy in cancer imaging, and reimbursement support.

By Service Provider:

• hospital
• Diagnostic Centers
• Research Institutes

Hospitals account for the largest market share by driving comprehensive diagnostic and treatment services, including PET-CT imaging, to a wide patient population.

By Application:

• oncology
• neurology
• cardiology
• others

Oncology dominates the market, which can be attributed to the utilization of PET-CT images in cancer diagnosis, staging, treatment planning, and response assessment.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others)
• Latin America (Brazil, Mexico, and others)
• Middle East & Africa

Asia-Pacific enjoys a leading position in the PET-CT scanner devices market owing to the increasing investments in healthcare infrastructure, rising prevalence of cancer, and increasing adoption of advanced medical imaging technologies.

Note: If you need specific information that is not currently included in the scope of the report, it will be provided as part of the customization.

About us:

IMARC Group is a leading market research firm that provides management strategy and market research worldwide. We partner with clients across all sectors and geographies to identify the most valuable opportunities, address the challenges that matter most, and transform their businesses.

IMARC's information products include key market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-tech companies. Market forecasting and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and new processing methods are at the top of our expertise.

Our services include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team of experienced researchers and analysts from a variety of industries is dedicated to providing high-quality data and insights to everything from small businesses to Fortune 1000 companies.

Contact

IMARC Group

134 N 4th St. Brooklyn, NY 11249 United States

E-mail sales@imarcgroup.com

Phone: (D) +91 120 433 0800

USA: +1-631-791-1145 | UK: +44-753-713-2163